Copyright Reports & Markets. All rights reserved.

Global Opioid Use Disorder Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Opioid Use Disorder Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Buprenorphine
      • 1.4.3 Methadone
      • 1.4.4 Naltrexone
    • 1.5 Market by Application
      • 1.5.1 Global Opioid Use Disorder Market Share by Application (2019-2025)
      • 1.5.2 Moderate Pain Treatment
      • 1.5.3 Severe Pain Treatment
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Opioid Use Disorder Market Size
    • 2.2 Opioid Use Disorder Growth Trends by Regions
      • 2.2.1 Opioid Use Disorder Market Size by Regions (2019-2025)
      • 2.2.2 Opioid Use Disorder Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Opioid Use Disorder Market Size by by Players
      • 3.1.1 Global Opioid Use Disorder Revenue by by Players (2014-2019)
      • 3.1.2 Global Opioid Use Disorder Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
    • 3.2 Opioid Use Disorder Key Players Head office and Area Served
    • 3.3 Key Players Opioid Use Disorder Product/Solution/Service
    • 3.4 Date of Enter into Opioid Use Disorder Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Opioid Use Disorder Market Size by Type (2014-2019)
    • 4.2 Global Opioid Use Disorder Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Opioid Use Disorder Market Size (2014-2019)
    • 5.2 Opioid Use Disorder Key Players in North America
    • 5.3 North America Opioid Use Disorder Market Size by Type
    • 5.4 North America Opioid Use Disorder Market Size by Application

    6 Europe

    • 6.1 Europe Opioid Use Disorder Market Size (2014-2019)
    • 6.2 Opioid Use Disorder Key Players in Europe
    • 6.3 Europe Opioid Use Disorder Market Size by Type
    • 6.4 Europe Opioid Use Disorder Market Size by Application

    7 China

    • 7.1 China Opioid Use Disorder Market Size (2014-2019)
    • 7.2 Opioid Use Disorder Key Players in China
    • 7.3 China Opioid Use Disorder Market Size by Type
    • 7.4 China Opioid Use Disorder Market Size by Application

    8 Japan

    • 8.1 Japan Opioid Use Disorder Market Size (2014-2019)
    • 8.2 Opioid Use Disorder Key Players in Japan
    • 8.3 Japan Opioid Use Disorder Market Size by Type
    • 8.4 Japan Opioid Use Disorder Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Opioid Use Disorder Market Size (2014-2019)
    • 9.2 Opioid Use Disorder Key Players in Southeast Asia
    • 9.3 Southeast Asia Opioid Use Disorder Market Size by Type
    • 9.4 Southeast Asia Opioid Use Disorder Market Size by Application

    10 India

    • 10.1 India Opioid Use Disorder Market Size (2014-2019)
    • 10.2 Opioid Use Disorder Key Players in India
    • 10.3 India Opioid Use Disorder Market Size by Type
    • 10.4 India Opioid Use Disorder Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Opioid Use Disorder Market Size (2014-2019)
    • 11.2 Opioid Use Disorder Key Players in Central & South America
    • 11.3 Central & South America Opioid Use Disorder Market Size by Type
    • 11.4 Central & South America Opioid Use Disorder Market Size by Application

    12 International Players Profiles

    • 12.1 Indivior
      • 12.1.1 Indivior Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Opioid Use Disorder Introduction
      • 12.1.4 Indivior Revenue in Opioid Use Disorder Business (2014-2019))
      • 12.1.5 Indivior Recent Development
    • 12.2 Alkermes
      • 12.2.1 Alkermes Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Opioid Use Disorder Introduction
      • 12.2.4 Alkermes Revenue in Opioid Use Disorder Business (2014-2019)
      • 12.2.5 Alkermes Recent Development
    • 12.3 Titan Pharmaceuticals
      • 12.3.1 Titan Pharmaceuticals Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Opioid Use Disorder Introduction
      • 12.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2014-2019)
      • 12.3.5 Titan Pharmaceuticals Recent Development
    • 12.4 Hikma Pharmaceuticals
      • 12.4.1 Hikma Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Opioid Use Disorder Introduction
      • 12.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2014-2019)
      • 12.4.5 Hikma Pharmaceuticals Recent Development
    • 12.5 Teva Pharmaceuticals
      • 12.5.1 Teva Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Opioid Use Disorder Introduction
      • 12.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2014-2019)
      • 12.5.5 Teva Pharmaceuticals Recent Development
    • 12.6 MediciNova
      • 12.6.1 MediciNova Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Opioid Use Disorder Introduction
      • 12.6.4 MediciNova Revenue in Opioid Use Disorder Business (2014-2019)
      • 12.6.5 MediciNova Recent Development
    • 12.7 Orexo
      • 12.7.1 Orexo Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Opioid Use Disorder Introduction
      • 12.7.4 Orexo Revenue in Opioid Use Disorder Business (2014-2019)
      • 12.7.5 Orexo Recent Development
    • 12.8 Camurus
      • 12.8.1 Camurus Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Opioid Use Disorder Introduction
      • 12.8.4 Camurus Revenue in Opioid Use Disorder Business (2014-2019)
      • 12.8.5 Camurus Recent Development
    • 12.9 Omeros
      • 12.9.1 Omeros Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Opioid Use Disorder Introduction
      • 12.9.4 Omeros Revenue in Opioid Use Disorder Business (2014-2019)
      • 12.9.5 Omeros Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
      Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
      In 2018, the global Opioid Use Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Opioid Use Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opioid Use Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Indivior
      Alkermes
      Titan Pharmaceuticals
      Hikma Pharmaceuticals
      Teva Pharmaceuticals
      MediciNova
      Orexo
      Camurus
      Omeros

      Market segment by Type, the product can be split into
      Buprenorphine
      Methadone
      Naltrexone

      Market segment by Application, split into
      Moderate Pain Treatment
      Severe Pain Treatment

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Opioid Use Disorder status, future forecast, growth opportunity, key market and key players.
      To present the Opioid Use Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Opioid Use Disorder are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now